TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |
PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
CCHCR1 |
Q8TD31
|
coiled-coil alpha-helical rod protein 1
|
|
1.0E-16 |
0.505 |
0.808 |
TCF19 |
Q9Y242
|
transcription factor 19
|
|
9.4E-04 |
0.674 |
0.692 |
ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
DDX39B |
Q13838
|
DExD-box helicase 39B
|
|
1.00 |
0.641 |
0.808 |
ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
MUC22 |
E2RYF6
|
mucin 22
|
|
1.4E-02 |
0.729 |
0.500 |
NELFE |
P18615
|
negative elongation factor complex member E
|
|
6.9E-03 |
0.686 |
0.500 |
CDSN |
Q15517
|
corneodesmosin
|
|
0.46 |
0.585 |
0.731 |
HLA-DPA2 |
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene)
|
|
|
0.780 |
0.538 |
FGFR1OP |
O95684
|
FGFR1 oncogene partner
|
|
6.3E-04 |
0.656 |
0.577 |
C1QTNF6 |
Q9BXI9
|
C1q and TNF related 6
|
|
9.0E-06 |
0.682 |
0.577 |
HLA-J |
|
major histocompatibility complex, class I, J (pseudogene)
|
|
|
0.861 |
0.269 |
BHLHB9P1 |
|
basic helix-loop-helix family member b9 pseudogene 1
|
|
|
1.000 |
0.115 |
CEP128 |
Q6ZU80
|
centrosomal protein 128
|
|
4.7E-23 |
0.780 |
0.423 |
SLA |
Q13239
|
Src like adaptor
|
|
0.34 |
0.736 |
0.500 |
FCRL3 |
Q96P31
|
Fc receptor like 3
|
Cell adhesion
|
6.0E-21 |
0.612 |
0.769 |
FCRL1 |
Q96LA6
|
Fc receptor like 1
|
Cell adhesion
|
4.0E-06 |
0.751 |
0.308 |